Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash Provided by (Used in) Operating Activities
Net earnings	$ 1,550	$ 1,121
Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization	65	53
Deferred income tax provision (benefit)	26	(72)
Earnings from equity investments	(157)	(86)
Loss on Cronos-related financial instruments	137	425
Asset impairment and exit costs, net of cash paid	(23)	17
Cash effects of changes:
Receivables	5	(16)
Inventories	(5)	(25)
Accounts payable	(45)	(189)
Income taxes	495	471
Accrued liabilities and other current assets	(421)	(513)
Accrued settlement charges	1,073	913
Pension plan contributions	(4)	(3)
Pension provisions and postretirement, net	(20)	(8)
Other, net	453	201
Net cash provided by (used in) operating activities	3,129	2,289
Cash Provided by (Used in) Investing Activities
Capital expenditures	(52)	(38)
Investment in Cronos	0	(1,831)
Other, net	0	(81)
Net cash provided by (used in) investing activities	(52)	(1,950)
Cash Provided by (Used in) Financing Activities
Proceeds from short-term borrowings	3,000	0
Repayment of short-term borrowings	0	(12,800)
Long-term debt issued	0	16,265
Long-term debt repaid	(1,000)	0
Repurchases of common stock	0	(151)
Dividends paid on common stock	(1,563)	(1,502)
Other, net	(10)	(129)
Net cash provided by (used in) financing activities	427	1,683
Cash, cash equivalents and restricted cash:
Increase (decrease)	3,504	2,022
Balance at beginning of period	2,160	1,433
Balance at end of period	5,664	3,455
Cash, cash equivalents and restricted cash	$ 5,664	$ 3,455